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A B S T R A C T
Background
Acute lower respiratory tract infections (LRTIs) (e.g. pneumonia) are a major cause of morbidity and mortality and management
focuses on early treatment. Chest radiographs (X-rays) are one of the commonly used strategies. Although radiological facilities are
easily accessible in high-income countries, access can be limited in low-income countries. The efficacy of chest radiographs as a tool in
the management of acute LRTIs has not been determined. Although chest radiographs are used for both diagnosis and management,
our review focuses only on management.
Objectives
To assess the effectiveness of chest radiographs in addition to clinical judgement, compared to clinical judgement alone, in the
management of acute LRTIs in children and adults.
Search methods
We searched CENTRAL 2013, Issue 1; MEDLINE (1948 to January week 4, 2013); EMBASE (1974 to February 2013); CINAHL
(1985 to February 2013) and LILACS (1985 to February 2013). We also searched NHS EED, DARE, ClinicalTrials.gov and WHO
ICTRP (up to February 2013).
Selection criteria
Randomised controlled trials (RCTs) of chest radiographs versus no chest radiographs in acute LRTIs in children and adults.
Data collection and analysis
Two review authors independently applied the inclusion criteria, extracted data and assessed risk of bias. A third review author compiled
the findings and any discrepancies were discussed among all review authors. We used the standard methodological procedures expected
by The Cochrane Collaboration.
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Main results
Two RCTs involving 2024 patients (1502 adults and 522 children) were included in this review. Both RCTs excluded patients with
suspected severe disease. It was not possible to pool the results due to incomplete data. Both included trials concluded that the use of
chest radiographs did not result in a better clinical outcome (duration of illness and of symptoms) for patients with acute LRTIs. In
the study involving children in South Africa, the median time to recovery was seven days (95% confidence interval (CI) six to eight
days (radiograph group) and six to nine days (control group)), P value = 0.50, log-rank test) and the hazard ratio for recovery was 1.08
(95% CI 0.85 to 1.34). In the study with adult participants in the USA, the average duration of illness was 16.9 days versus 17.0 days
(P value > 0.05) in the radiograph and no radiograph groups respectively. This result was not statistically significant and there were no
significant differences in patient outcomes between the groups with or without chest radiograph.
The study in adults also reports that chest radiographs did not affect the frequencies with which clinicians ordered return visits or
antibiotics.However, there was a benefit of chest radiographs in a subgroup of the adult participants with an infiltrate on their radiograph,
with a reduction in length of illness (16.2 days in the group allocated to chest radiographs and 22.6 in the non-chest radiograph group,
P < 0.05), duration of cough (14.2 versus 21.3 days, P < 0.05) and duration of sputum production (8.5 versus 17.8 days, P < 0.05).
The authors mention that this difference in outcome between the intervention and control group in this particular subgroup only was
probably a result of “the higher proportion of patients treated with antibiotics when the radiograph was used in patient care”.
Hospitalisation rates were only reported in the study involving children and it was found that a higher proportion of patients in the
radiograph group (4.7%) required hospitalisation compared to the control group (2.3%) with the result not being statistically significant
(P = 0.14). None of the trials report the effect on mortality, complications of infection or adverse events from chest radiographs. Overall,
the included studies had a low or unclear risk for blinding, attrition bias and reporting bias, but a high risk of selection bias. Both trials
had strict exclusion criteria which is important but may limit the clinical practicability of the results as participants may not reflect
those presenting in clinical practice.
Authors’ conclusions
Data from two trials suggest that routine chest radiography does not affect the clinical outcomes in adults and children presenting to
a hospital with signs and symptoms suggestive of a LRTI. This conclusion may be weakened by the risk of bias of the studies and the
lack of complete data available.
P L A I N L A N G U A G E S U M M A R Y
Chest X-rays in acute chest infections
Acute chest infections (lower respiratory tract infections) such as pneumonia, bronchitis and bronchiolitis are a major cause of deaths
worldwide and expected to be amongst the leading four causes of death by 2030. The most affected population groups are children
under 59 months and adults over 50 years of age. Patients with chest infections often have a fever, cough, shortness of breath and
phlegm production. A chest X-ray is commonly used to help diagnose and manage chest infections and is widely used in high-income
countries. However, the impact of chest X-rays in terms of how they may change patient recovery in suspected chest infection has not
been evaluated. We focused on whether the use of chest X-rays compared to not using them led to improved outcomes such as a faster
recovery rate, less time in hospital and fewer complications for the patient. We did not investigate the use of chest X-rays as a tool in
the diagnosis of chest infections or the differences in the interpretation of X-rays between doctors.
Two trials with a total of 2024 participants were included in this review. The trial published in 1983 in the USA included only adults,
while the trial in 1998 in South Africa included only children. Both trials were set in large metropolitan cities. We were unable to
combine the results of the two studies due to incomplete data. However, both trials came to the same conclusion regarding the use
of chest X-rays in chest infections, except in the subgroup of patients with evidence of infection (infiltrates) on their X-rays. In both
adults and children, chest X-rays did not result in significant differences in recovery time.
In summary, there were no differences in patient outcomes between the groups with or without chest X-ray. Although both studies
suggest that chest X-rays do not improve patient outcomes, it is not clear if this finding can be applied to all populations and settings.
Results may be different in resource poor countries. Our conclusions are limited due to the lack of complete data available and by the
risk of bias of the studies. Adverse effects of chest X-rays were not assessed by either study. We assessed the quality of the evidence from
both trials as being moderate. For the remainder of this review, X-rays will be referred to as radiographs.
The evidence is current as of February 2013.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
The effectiveness of chest radiographs in addition to clinical judgement compared with clinical judgement alone for acute lower respiratory tract infections
Patient or population: adults and children with clinical signs and symptoms of acute lower respiratory tract infect ion
Settings: South Af rica and USA
Intervention: chest radiographs and clinical judgement
Comparison: clinical judgement alone, without the use of chest radiographs
Outcomes Illustrative comparative risks* (95% CI) No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Without chest radiograph
(control)
With chest radiograph
M ortality Adults - - - - Not assessed
Children 0 0 518 (1) ⊕⊕⊕©
moderate
Not included as an out-
come, however it was re-
ported that ‘‘no deaths
were recorded’’ during the
trial
Time to resolution
of clinical signs and
symptoms
[days]
Adults 17.0 16.9 1502 (1) ⊕⊕©©
low
Average durat ion of illness
in the radiograph group
was 16.9 days and 17.0
days in the no radiograph
group (P > 0.05)
Relat ive risks not provided
in original RCT
Inadequate data provided
in original RCT - further
analysis of these data
could not be conducted as
a specif ic P value was not
stated (only whether the P
value was greater or less
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than 0.05)
Follow-up cont inued to ei-
ther end of illness or for at
least 1 month af ter presen-
tat ion
Downgraded to low qual-
ity due to risk of bias
and the lack of evidence
that the est imate excludes
clinically meaningful dif -
f erences in either direct ion
Children 7 (95% CI 6 to 9) 7 (95% CI 6 to 8) 518 (1) ⊕⊕©©
low
Median t ime to recovery in
control group was 7 days
(95% CI 6 to 9 days) and in
the chest radiograph group
was 7 days (95% CI 6 to 8
days)
P = 0.50, log-rank test
Hazard rat io for recovery
was 1.08 (95% CI 0.85 to
1.34)
Follow-up unt il recovery or
censored at 28 days
Downgraded to low quality
due to risk of bias and the
lack of evidence that the
est imate excludes mean-
ingful dif f erences in either
direct ion
Hospitalisation rates Adults - - - - Not reported. Data only
provided in subgroup of
pat ients that was not ran-
domised
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Children 2.3% (6 of 261 children) 4.7% (12 of 257 children) 518 (1) ⊕⊕©©
low
The est imated risk rat io for
this study was 2.03 (0.77
to 5.03). Not stat ist ically
signif icant (P = 0.154)
Downgraded to low quality
due to risk of bias and im-
precision of data
Complications of in-
fection
Adults - - - - Not assessed
Children - - - - Not assessed
Adverse effects from
chest radiographs
Adults - - - - Not assessed
Children - - - - Not assessed
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; P: P value; NNT: number needed to treat; RCT: randomised controlled trial; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
Bushyhead 1983: lim itat ions in the design and implementat ion of available studies suggest ing high risk for detect ion bias and
low or unclear risk for select ion, attrit ion and report ing bias (Risk of bias in included studies).
Swingler 1998: lim itat ions in the design and implementat ion of the study suggest ing high risk for select ion and attrit ion bias
and low risk for detect ion and report ing bias (Risk of bias in included studies).
No serious risk of unexplained heterogeneity or publicat ion bias in either of the trials. Both outcomes for t ime to resolut ion of
symptoms and hospitalisat ion rates in both trials were downgraded to ’low quality’ due to imprecision of results.
A column for relat ive ef fects was not included as part of the ’Summary of f indings’ table as data needed to calculate relat ive
risks were not presented in either of the included trials.
Although mortality in children did not occur, we have included this in our Summary of f indings for the main comparison as it
may ref lect the severity of illness and the use of appropriate management.
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B A C K G R O U N D
(’Lower respiratory tract infections’ are referred to as ’chest infec-
tions’ in the ’Plain language summary’).
Description of the condition
Lower respiratory tract infections (LRTIs) are infections that occur
below the level of the larynx and include pneumonia, bronchitis
and bronchiolitis. These tend to be more severe in nature than
upper respiratory tract infections (infections above the level of the
pharynx). In this review we will only focus on LRTIs.
LRTIs are the third leading cause of death worldwide after coro-
nary heart disease and stroke, and are expected to be amongst
the leading four causes of death by 2030, with pneumonia ac-
counting for a significant proportion (WHO 2004). According to
the World Health Organization (WHO), there were 3.2 million
deaths worldwide in 2011 due to LRTIs, with 1.1 million deaths
in the African region alone (WHO 2011). The most affected pop-
ulation groups were children under 59 months of age and adults
over 50 years of age (WHO 2011).
Pneumonia is referred to as the inflammation of one or both lungs
with consolidation and is classified by the causative organism, such
as bacteria, virus, fungi or protozoa (WHO 2013; Yang 2013).
Between 2004 and 2005, the hospitalisation rate for pneumonia
in England was 1.98 per 1000 population (Trotter 2008). It is the
leading cause of mortality in children less than five years of age
(Lodha 2013). The diagnosis and management of this condition
is associated with significant costs (Bjerre 2009). Complications
may include effusion, empyema, abscess, sepsis and lung failure
resulting in death (Mandell 2007).
Bronchitis is the inflammation and irritation of the trachea and
bronchi. It is caused by viral or bacterial pathogens as well as res-
piratory irritants such as dust or fumes. Nearly all cases of acute
bronchitis are self limiting (Smith 2011). In Australia this respi-
ratory disorder is the fifth most common presentation to Gen-
eral Practitioners (Wark 2008). Chronic bronchitis refers to a pro-
ductive cough for at least three months of each of two successive
years for which other causes have been ruled out (WHO 2013).
Chronic bronchitis is mostly linked to longstanding conditions
such as emphysema and asthma. In 2007, 4.4% of adults were
diagnosed with chronic bronchitis in the USA (Pleis 2008).
Bronchiolitis is a virally induced acute bronchiolar inflammation
associated with airway obstruction that affects infants younger
than two years of age. The severity of the disease can range from
mild to severe, and clinically manifests with rhinorrhoea, expira-
tory wheezing and a cough (Lozano 2007). The most common
viral cause is respiratory syncytial virus (Roqué i Figuls 2012). Al-
though it can be a life-threatening illness, the mainstay of treat-
ment is supportive care and there is no clear evidence for the ef-
fectiveness of antibiotics (Spurling 2011).
Description of the intervention
Chest radiographs are routinely used as a tool to diagnose and
screen for acute respiratory tract infections of the lower respira-
tory system including pneumonia, tuberculosis, bronchiolitis and
emphysema. For example, community-acquired pneumonia is di-
agnosed based on the presence of pulmonary infiltrate on chest
radiographs and the clinical signs and symptoms of the patient
(Ruiz 2000). However, in practice there appears to be an “undue
reliance on the clinical diagnosis of community-acquired pneu-
monia” and a chest radiograph may be done only when the diag-
nosis is uncertain (Mandell 2010).
Management of many LRTIs, especially pneumonia, focuses on
the early detection and treatment of the disease. Chest radiographs
are one of the commonly used strategies. However, it has been sug-
gested that there can be substantial differences in their interpreta-
tion by clinicians and radiologists (Hopstaken 2004). This review
focuses on the efficacy of chest radiographs in treating LRTIs and
therefore we will not include studies on other strategies such as
computed tomography (CT) or on the inter-observer differences
in interpretations of chest radiographs.
How the intervention might work
Chest radiographs are used as an investigation to confirm or re-
fute possible diagnoses. They are an objective measure which can
not only confirm a suspected disease such as pneumonia but can
also define the severity, for example, multiple lung lobes and any
associated complications such as pleural effusions and cavitations
(ATS 2005). Chest radiographs are accepted as the gold standard
in the diagnosis of pneumonia (Woodhead 2005). However, there
is no clear radiological definition for the diagnosis of pneumonia,
rather a spectrum of radiological appearances ranging frommulti-
focal lobular consolidation to diffuse interstitial changes (Gharib
1990). Conversely, different diseases may appear similar radiolog-
ically, for example, bacterial pneumonia, pulmonary tuberculo-
sis in HIV-positive people and pneumocystis carinii pneumonia
(Boiselle 1997). Although the presence of radiographic findings is
highly suggestive of a diagnosis, an absence of findings does not
necessarily preclude the disease (Basi 2004).
Why it is important to do this review
Although chest radiographs are routinely used in the management
of acute LRTIs, the efficacy of this diagnostic tool in their treat-
ment has not been determined. This is important for clinicians to
know so that unnecessary chest radiographs will not be ordered.
This will decrease healthcare costs for the patient on an individual
level and ensure better allocation of healthcare resources and fund-
ing on a population level. Furthermore, the cumulative effect of
radiation from multiple chest radiographs could potentially lead
to the development of malignant conditions or cause or exacerbate
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pre-malignant processes. This review aims to address this issue so
that clinicians can weigh up the potential benefits and harms of
using chest radiographs in order to achieve the best outcome for
patients. We specifically focus on the use of radiographs as a clini-
cal tool for management rather than their use as a diagnostic tool.
We did not investigate the inter-observer differences in interpreta-
tion of the radiographs between clinicians or radiologists, or both.
O B J E C T I V E S
To assess the effectiveness of chest radiographs in addition to clini-
cal judgement, compared to clinical judgement alone, in the man-
agement of acute LRTIs in children and adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs). As double-blinding is not
feasible, open studies and studies with outcome assessor blinding
were eligible.
Types of participants
Adults and children with clinical signs and symptoms of an acute
LRTI, for example, cough, fever, dyspnoea, feeling generally un-
well, etc.
Types of interventions
Chest radiograph (posterior-anterior and lateral views) compared
with no chest radiograph prior to initiation of management.
Types of outcome measures
Primary outcomes
1. Mortality.
2. Time to resolution of clinical signs and symptoms (patient’s
presenting symptoms and findings on physical examination such
as reduced breath sounds, crackles, dull percussion note, etc.).
Secondary outcomes
1. Hospitalisation rates.
2. Any complications of the infection (for example, abscess,
pleural effusion, septicaemia, respiratory failure).
3. Adverse effects from chest radiographs (for example,
malignant conditions).
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) 2013, Issue 1, part of The Cochrane Library,
www.thecochranelibrary.com (accessed 5 February 2013), MED-
LINE (1948 to January week 4, 2013), EMBASE (1974 to Febru-
ary 2013), CINAHL (1981 to February 2013) and LILACS (1982
to February 2013). See Figure 1.
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Figure 1. Flow diagram of study selection and inclusion.
We used the following search strategy to search MEDLINE
and CENTRAL. We combined the MEDLINE search with the
Cochrane Highly Sensitive Search Strategy for identifying ran-
domised trials in MEDLINE (Appendix 1): sensitivity- and preci-
sion-maximising version (2008 revision); Ovid format (Lefebvre
2011). We adapted the search strategy to search EMBASE
(Appendix 2), CINAHL (Appendix 3), LILACS (Appendix 4),
ClinicalTrials.gov (Appendix 5) andWHO ICTRP (Appendix 6).
Searching other resources
We searched DARE and NHS EED 2013, Issue 1, part of The
Cochrane Library, www.thecochranelibrary.com (accessed 5 Febru-
ary 2013) to identify any relevant systematic reviews in order to
check the reference lists for randomised trials. We also searched
ClinicalTrials.gov on 19 February 2013 and theWorldHealthOr-
ganization International Clinical Trials Registry Platform (WHO
ICTRP) on 23 February 2013. We handsearched the reference
lists of RCTs for additional studies, searched the trial registers for
ongoing or recent trials and contacted experts in the field about
any unpublished or ongoing studies. We contacted Professor GH
Swingler who was the author of both Swingler 1998 and the origi-
nal Cochrane Review Swingler 2008 in order to obtain additional
data when there was insufficient information reported in the pub-
lication of the included trial or missing relevant data. We did not
apply any publication, time or language restrictions in our search.
Data collection and analysis
All review authors independently performed study selection. All
review authors assessed studies for trial quality and extracted data.
Selection of studies
Two review authors (AC, JC) independently assessed and evaluated
potential studies for inclusion in this review. One review author
(LM) independently evaluated any disagreements and discrepan-
cies (with guidance fromMLvD) and all review authors discussed
results until a consensus was reached.
Data extraction and management
Two authors (AC, JC) independently collected and extracted the
data from the studies. A third review author (LM) resolved any
disagreements through further discussion with all review authors
until a consensus was reached. We described the data extracted in
the Characteristics of included studies table.
Assessment of risk of bias in included studies
We assessed the risk of bias by evaluating whether there was
adequate random sequence generation, allocation concealment,
blinding of outcome assessment, if incomplete outcome data were
discussed for short and longer-term outcomes and whether studies
were free of selective reporting and other bias, for example, conflict
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of interest of authors, publication bias, etc. (Higgins 2011). We
assessed the following potential sources of bias as ’low risk’, ’high
risk’ or ’unclear’ (if insufficient information was available to make
a clear judgement):
• selection bias, i.e. sequence generation and allocation
concealment;
• performance and detection bias, i.e. blinding of participants
and personnel;
• detection bias, i.e. blinding of outcome assessment;
• attrition bias, i.e. incomplete outcome data;
• reporting bias, i.e. selective reporting;
• other sources of bias, for example, setting, conflict of
interest of authors, publication bias.
Measures of treatment effect
We presented dichotomous data, such as mortality, as a risk ra-
tio (RR) with 95% confidence intervals (CIs). We expressed the
estimate of clinical effect as numbers needed to treat to bene-
fit (NNTB). We presented continuous data as mean differences
(MDs) with their standard deviations (SDs).
Unit of analysis issues
We included studies where the unit of analysis is the unit of ran-
domisation. We did not identify any cluster-RCTs and therefore
did not need to apply adjustment as outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Dealing with missing data
We contacted Professor GH Swingler who was the author of
this original review (Swingler 2008) via email for additional data
(NNTB at 14 days) that was published in the original review but
not published in the trial Swingler 1998. Unfortunately, the orig-
inal unpublished data could not be found. As additional outcome
data were not available, we performed intention-to-treat (ITT)
analysis. In ITT analysis patients for whom outcome data were
missing are considered as treatment failures for the meta-analysis.
Assessment of heterogeneity
We assessed heterogeneity in a two-stepped process. We first as-
sessed similarities at face value (for example, similar setting, partic-
ipant population, randomisation method). Secondly, we assessed
statistical heterogeneity by using the Chi2 test with a P value of <
0.10 as a cut-off for statistical significance and the I2 statistic with
a cut-off value of 40% as indicating important heterogeneity as
outlined in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011). In the presence of heterogeneity we did
not pool the studies (face value heterogeneity) or used a random-
effects model (presence of statistical heterogeneity). In the absence
of heterogeneity we used a fixed-effect model (Higgins 2011).
Assessment of reporting biases
Weplanned to perform a funnel plot analysis to assess the presence
of publication bias. However, an insufficient number of studies
(i.e. fewer than 10) were identified for this review. We reported the
conflict of interest declarations of the trial authors where available.
We assessed detection bias, i.e. if there was blinding of outcomes
assessment for the assessors and the patients. We also assessed
attrition bias, i.e. if the withdrawals were described and if an ITT
analysis was performed.
Data synthesis
We synthesised data from the RCTs using Review Manager
(RevMan 2012) software.
Subgroup analysis and investigation of heterogeneity
We planned to investigate the following subgroups.
1. Infants under two years versus older children.
2. Adults versus elderly (aged > 65 years).
3. Early versus later chest radiograph (i.e. before or after 48
hours since start of symptoms).
4. ITT analysis versus on-treatment analysis.
We attempted to obtain individual data from authors of included
studies to attempt individual patient data meta-analysis; unfortu-
nately no individual patient data were available for meta-analysis.
Sensitivity analysis
We planned to perform sensitivity analyses by investigating the
impact of risk of bias and heterogeneity on the overall estimate of
effect. We first pooled studies with a low risk of bias and subse-
quently added studies with a high risk of bias in order to assess the
impact of risk of bias on the overall outcome. In order to investi-
gate the impact of heterogeneity on the overall estimate of effect
we had planned to remove studies that seemed (by inspecting the
forest plot and identifying the ’outliers’) to contribute to hetero-
geneity and compared the overall outcomes. However, due to the
lack of data and the limited number of included trials this was not
possible.
R E S U L T S
Description of studies
See Figure 1 for a breakdown of study search results and included
studies.
We contacted Professor GH Swingler, the author of both Swingler
1998 and the original Cochrane Review Swingler 2008 to ob-
tain unpublished data that was not reported in the original trial
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(Swingler 1998) but was included as part of the results in the
original Cochrane Review (Swingler 2008). However, Professor
Swingler was not able to locate the data from which the calcu-
lations (numbers needed to treat) were derived. We have not in-
cluded these unpublished data as they could not be verified.
Results of the search
Searching the electronic databases retrieved a total of 1195 records
after duplicates were removed. There were 582 records retrieved
from the MEDLINE search, 71 records retrieved from CEN-
TRAL, 345 records from EMBASE, 136 records from CINAHL,
53 records from LILACS, none from DARE, one record from
NHS EED, four records from ClinicalTrials.gov and three records
from WHO ICTRP (Figure 1).
Included studies
Of the 1195 studies found, eight appeared to be relevant to our
review (Bourayou 2011; Briel 2006; Bushyhead 1983; Colucci
2012; Lynch 2004; Ralston 2012; Swingler 1998; Swingler 2000).
After further analysis, two studies were included in our review
(Bushyhead 1983; Swingler 1998). The other six studies were ex-
cluded (Bourayou 2011; Briel 2006; Colucci 2012; Lynch 2004;
Ralston 2012; Swingler 2000).
Design
Both included trials were RCTs.
Sample size and setting
Bushyhead 1983 enrolled 2018 participants, was conducted in the
emergency room and walk-in clinic of an Army Medical Centre
in Texas, USA and consisted of three phases. However, only Phase
III was relevant to our review and, thus, only Phase III was ana-
lyzed. Phase III included 1502 adults (1531 enrolled but 29 were
excluded). Swingler 1998 included 522 children (581 enrolled but
59 were excluded) and was conducted in a children’s teaching hos-
pital in South Africa (Red Cross Children’s Hospital).
Participants
Participants in Bushyhead 1983 were adult, non-pregnant, mainly
retired, military personnel and their dependents with a small pro-
portion being active duty army troops. Patients with a cough last-
ing less than one month at the first presentation were included in
the trial. Patients who had a pulse rate of 160 or more, temper-
ature 104 °F (40 °C) or more, systolic blood pressure 90 mmHg
or lower or patients arriving by stretcher were excluded from the
trial. Participants in Swingler 1998 were children aged between 2
and 59 months old who met the WHO case definition for pneu-
monia. Excluded participants in Swingler 1998 included children
presenting with a “cough of more than 14 days duration, history
of current household contact with active tuberculosis, a localised
wheeze, clinical signs of cardiac failure or [when] the clinician’s
assessment that a chest radiograph was mandatory”.
Interventions
The Bushyhead 1983 trial was divided into three phases. In Phase
I, chest radiographs were only taken on physicians’ request and
all requested radiographs were seen by all physicians (n = 199),
resembling practice as usual. In Phase II, chest radiographs were
taken of all patients but physicians only saw the films if they had
ordered them (n = 288). Phase III was the largest phase of the study
with 1502 participants. In Phase III, chest radiographs were taken
of all patients and it was determined by lot with 1:1 odds randomi-
sation whether physicians would receive the radiology report and
film. Physicians recorded their diagnosis and management plan
as well as their prediction of the most likely finding on the chest
radiograph, prior to being told if they could see the chest radio-
graph. They also noted if they wished to order a chest radiograph
for each patient. Physicians were allowed to change the diagnosis
and management plans only if their patient was allocated to the
chest radiograph group.
In the Swingler 1998 trial, children were randomly allocated to
have chest radiographs (both anteroposterior and lateral views)
or no chest radiograph. The chest radiographs were seen by the
clinician and a report was available with the films. The control
intervention was standard care without a chest radiograph.
Outcomes
Bushyhead 1983 investigated the effect of chest radiographs on the
management and clinical course of patients with a cough. How-
ever, their primary objective was to investigate whether the use of
providing chest radiographs influenced the physician’s decisions,
i.e. the addition of antibiotics, changes in management plans and
also illness outcomes (e.g. returned visits, hospitalisation time, du-
ration of symptoms and illness).
Swingler 1998 investigated the “effect of chest radiographs on the
management and clinical outcome in children with ambulatory
acute lower respiratory [tract] infection”with the primary outcome
measure being the time to recovery. Subsidiary outcomes included
other management options used such as antibiotics and admission
to hospital.
Excluded studies
We excluded six studies (Bourayou 2011; Briel 2006; Colucci
2012; Lynch 2004; Ralston 2012; Swingler 2000). Bourayou 2011
was a literature review on the diagnostic value of chest radiography
rather than the use of chest radiographs as a management tool in
LRTIs. Briel 2006 investigated how test results affected manage-
ment decisions but did not distinguish between the use of chest
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radiographs and other blood tests and data for chest radiographs
only could not be extracted. Although the objective of Colucci
2012 was to determine whether the management of pneumonia
correlated to radiography, it was excluded because it was retrospec-
tive. Lynch 2004 was excluded because its primary outcome was
irrelevant to our review. Lynch 2004 aimed to investigate the “dif-
ference in sensitivity and specificity of the emergency physicians’
interpretations of chest radiographs”. Ralston 2012 was excluded
as it was not aRCTand because its objective was for quality control
by reducing interventions for acute viral bronchiolitis. Swingler
2000 was excluded because it appeared to be a duplication of the
Swingler 1998 study but with an emphasis on case finding for
tuberculosis. No ongoing studies or studies awaiting classification
were identified.
Risk of bias in included studies
A visual summary of the risk of bias in the included studies is
presented in Figure 2 and Figure 3.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
Allocation
In the Swingler 1998 trial, the principal investigator generated
the random numbers by tossing a coin for each sequentially num-
bered envelope. A study nurse identified eligible patients whowere
subsequently seen by the clinician. For each eligible patient, a se-
quentially numbered “manila envelope” containing the random
allocation was attached to the consultation sheet. The clinician
was blinded to the content of the envelope prior to opening it. If
a patient was withdrawn before randomisation, the envelope was
returned to the investigator and this was audited. Thus, the risk
of selection bias for this trial is high.
In Phase III of the Bushyhead 1983 trial, the random sequence
generation was described as “determined by lot with 1:1 odds”
who would receive the chest radiographs and the radiologist’s re-
port. However, it was not described how the random numbers
or “lots” were generated, who did this and how it was commu-
nicated to the participating physicians. Thus, the risk of bias is
unclear. Regarding the allocation concealment in Phase III of the
trial, “we required clinicians to record diagnoses and management
plans for all patients before they knew whether or not they would
see the chest films...They noted whether they wished to order a
chest radiograph for the patient and if so, why. These decisions
had no bearing on whether the physicians saw the radiographs.”
Therefore, the risk of bias for allocation concealment for Phase III
of the trial is low.
Blinding
In Bushyhead 1983, the research assistants who collected a stan-
dard history from all patients at inclusion were blinded to the
12Chest radiographs for acute lower respiratory tract infections (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
randomisation status of the patient. The chest radiographs were
read by radiologists who were unaware of the patient’s clinical pre-
sentation other than that they had an acute cough. The effect on
patient outcomes (duration of illness and disability) was assessed
by research assistants who contacted the participants by telephone
every four weeks.However, assessment of secondary outcomes was
not blinded and therefore the risk of detection bias is high.
In Swingler 1998, the primary outcome (time to recovery) was
assessed by research assistants who contacted the participants by
telephone twice weekly. The telephone interviewer was blinded to
the randomisation status of the patient on follow-up but also to the
study objectives. The principal investigator examined the clinical
records of all patients to ascertain all other outcomes. Coding of
the collected data from the telephone interviews was performed by
the principal investigator who had no knowledge of the group the
patients were allocated to and was entered in a separate database.
Therefore, the risk of detection bias is low.
Incomplete outcome data
In both trials, all participants were accounted for and also ITT
analysis was performed. In Bushyhead 1983, 2% of patients were
excluded from randomisation as physicians felt that viewing the
chest films was needed to evaluate their condition. There were four
patients lost to follow-up inBushyhead 1983.However, three were
patients with masses and the other one presented with weight loss.
It would have been unlikely for this to have affected the overall
outcome of the study.
Swingler 1998 attempted to follow-up a subset (365 participants)
of the total number of participants (581) enrolled. Of this sub-
set, 22% were lost to telephone follow-up. Although it was men-
tioned that the loss was similar between treatment groups, this is
nonetheless a significant proportion of patients that were lost to
follow-up.
Selective reporting
For both studies, there were no trial protocols available to us.How-
ever, in both Bushyhead 1983 and Swingler 1998 all outcomes
were reported. Thus, we considered both trials to have low risk of
selective reporting.
Other potential sources of bias
In the Bushyhead 1983 study, only patients who verbally agreed
to the Phase III protocol were included in Phase I of the study.
Although this aimed to ensure the study population in those two
phaseswould be comparable, whether thiswould have significantly
altered the selected patient population is unclear.
No other potential sources of bias were identified in either trial
(e.g. baseline imbalance, deviation from study protocols in a way
that does not reflect clinical practice, pre-randomisation of inter-
ventions). Neither Bushyhead 1983 nor Swingler 1998 reported
conflicts of interest or financial disclosures. However, Swingler
1998 “was supported by the Medical Research Council of South
Africa and the University of Cape Town.” No further informa-
tion regarding themethod in which theMedical Research Council
of South Africa and the University of Cape Town supported this
study was provided. Therefore, the risk of bias for both studies is
unclear.
Effects of interventions
See: Summary of findings for the main comparison
Refer to Summary of findings for the main comparison.
Primary outcomes
1. Mortality
This outcome was not assessed by the studies included in this
review. However, Swingler 1998 states that “no deaths were
recorded” during the trial (followed up for 28 days).
2. Time to resolution of clinical signs and symptoms
Both studies included in this review (Bushyhead 1983; Swingler
1998), with a total of 2024 participants (1502 adults in Phase III
of Bushyhead 1983 and 522 children in Swingler 1998), assessed
time to resolution of clinical signs and symptoms (Analysis 1.1).
In Bushyhead 1983, the overall length of illness was 16.9 days in
the group with chest radiographs compared to 17.0 days in the
group without a provided radiograph (P > 0.05). There were also
no statistically significant differences in the average duration of
symptoms between the two groups. Duration of cough was 15.0
days when radiographs were provided and 15.2 days when they
were not provided. Duration of sputum production was 10.0 days
with radiographs compared to 10.5 days without radiographs.Du-
ration of fever was 0.44 days compared to 0.64 days when ra-
diographs were not given to the physicians. Duration of reported
fatigue was 5.4 days compared to 4.9 days. In patients with infil-
trates (n = 41), however, use of the chest radiograph was associated
with a reduction in the length of illness (16.2 days in the group al-
located to chest radiographs and 22.6 in the non-chest radiograph
group, P < 0.05), duration of cough (14.2 versus 21.3 days, P <
0.05) and duration of sputum production (8.5 versus 17.8 days,
P < 0.05). The authors mention that this difference in outcome
between the intervention and control group was probably a re-
sult of “the higher proportion of patients treated with antibiotics
when the radiograph was used in patient care.” Further analysis of
these data could not be conducted as a specific P value (rather than
one that was greater or less than 0.05) for the average duration of
symptoms was not stated.
In Swingler 1998, 295 out of the 522 participants could be con-
tacted by telephone enabling follow-up until recovery or were cen-
sored at 28 days. “The median time to recovery was 7 days for
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both groups (95% confidence interval (CI) 6 to 8 days in the ra-
diograph group and 6 to 9 days in the control group, P = 0.50, log-
rank test).” (Figure 4). However, as only the median was reported
and no mean for these data was stated, further analysis was not
possible (Table 1). The hazard ratio for recovery was 1.08 (95%CI
0.85 to 1.34). Additional unpublished data from Swingler 1998,
which were published in Swingler 2008, showed that the “relative
risks for remaining ill at four and 14 days were 0.01 (95% CI 0.78
to 1.07) and 0.85 (95% CI 0.53 to 1.37) respectively”.
Figure 4. Forest plot of comparison: 1 Chest radiograph versus management without chest radiograph
(children only), outcome: 1.2 Hospitalisation rates.
Secondary outcomes
1. Hospitalisation rates
In Bushyhead 1983, hospitalisation rates were not reported. Data
for hospitalisation rates were only provided for the subgroup of
patients for whom their treating doctor insisted on chest radiog-
raphy. This subgroup was not randomised and is not included in
our review.
In Swingler 1998, a higher proportion of patients randomised to
the intervention group (4.7%) required hospitalisation compared
to the comparator group (2.3%) (Analysis 1.2). However, this
result was not statistically significant (P = 0.14) (Figure 4).
2. Complications of infection
This outcome was not assessed by the studies included in this
review.
3. Adverse effects from chest radiographs
This outcome was not assessed by the studies included in this
review.
D I S C U S S I O N
Summary of main results
Our review found two trials that investigated the effect of chest
radiographs in lower respiratory tract infections (LRTIs); one in
adults (Bushyhead 1983) and one in children (Swingler 1998).
Severely ill patients were excluded from both randomised con-
trolled trials (RCTs). Both trials came to the conclusion that mak-
ing chest radiograph results available to clinicians resulted in simi-
lar outcomes for patients with acute LRTIs compared to when no
chest radiograph results were available.
For cases in adults, Bushyhead 1983 states that the differences
in outcomes between the group with chest radiographs and the
group without were not statistically significant. This suggests that
chest radiographs did not result in significant changes in man-
agement plans or differences in patient outcomes. However, chest
radiographs appear to be of benefit in the subgroup of the par-
ticipant population with an infiltrate on their radiograph. In this
subgroup of patients whose chest radiographs showed infiltrative
abnormalities, the “use of the chest radiograph was associated with
[a] reduction in the length of illness, duration of cough, and du-
ration of sputum production (P < 0.05)”. This effect was not evi-
dent in patients whose chest radiographs showed non-infiltrate ra-
diographic abnormalities. It was interesting to note that although
patients with non-infiltrate radiographic abnormalities often had
additional return visits, diagnostic tests and changes in treatment,
these changes were rarely effective, i.e. rarely led to improved pa-
tient outcomes. Bushyhead 1983 reported that “chest radiographs
were not ordered efficiently by physicians”. It is also interesting
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to note that only 54% of patients with infiltrates on chest radio-
graphs would have had chest radiographs ordered by the treating
physician under normal practice conditions. None of the other
46% of patients would have been suspected to have pneumonia
despite definite radiographic infiltrates. Nonetheless, this finding
has limited practical implications as, to date, the simplest andmost
accessible way of knowing whether patients will have pulmonary
infiltrates is to perform a chest radiograph.
For cases in children, Swingler 1998 states that “there are no clin-
ically identifiable subgroups of children within the WHO case
definition of pneumonia who are likely to benefit from a chest ra-
diograph.” Swingler 1998 summarised that “the most favourable
95% CI for the estimate of benefit of a chest radiograph is the
prevention of 3 days of relatively trivial symptoms, while the least
favourable is the cause of an additional 2 days of symptoms”. It was
thought-provoking to note that at 28 days, every 11 chest radio-
graphs performed in children would result in one more antibiotic
script (95% CI -5.8 to 61.7). Additionally, every 42 chest radio-
graphs performed at 28 days would lead to one additional hospital
admission (95% CI -18 to 127). Swingler 1998 concluded that
“the use of chest radiographs did not reduce time to recovery or
subsequent health-facility use in children over two months with
ambulatory acute lower-respiratory [tract] infection” and hence
recommended that “chest radiographs should not be routinely
done in this group of patients” (Figure 4).
According to Swingler 1998, the effect of chest radiographs was
independent of both the severity of the respiratory tract infection
and the clinician’s clinical experience. The patient’s “age, weight
for age, duration of symptoms before presentation, respiratory
rate, or the clinicians’ perception of the need for a radiograph”
did not influence the effect of the chest radiograph. This effect is
also not influenced by the clinicians’ qualifications or experience,
i.e. whether they were recently qualified doctors with no previous
paediatric outpatient experience or had a postgraduate paediatric
qualification.
With regard tohospitalisation rates, Swingler 1998 reported higher
hospitalisation rates for patients randomised to chest radiographs
but this result was not statistically significant (Figure 4). Unfortu-
nately, Bushyhead 1983 did not analyze hospitalisation rates for
patients whose radiographs were provided versus those for whom
radiographs were not provided, which is one of the objectives of
our review. Instead Bushyhead 1983 reported hospitalisation rates
in the group of patients whose radiographs were provided to their
physicians and compared whether the wishes of the physician to
view the radiograph or not had an impact on the patients’ hospi-
talisation rates.
Both RCTs set strict exclusion criteria that excluded patients with
suspected severe disease, either based on variations in patients’
vital signs, other clinical signs of severe disease such as localised
wheeze or when the clinicians’ assessment deemed chest radio-
graphs mandatory. Strict exclusion criteria are important but may
limit the clinical practicability of the results of the trials as both
study populations were well-filtered sample populations which
may not reflect those presenting in clinical practice.
There were no data available from the included studies to assess
the impact on mortality, complications of infection and adverse
effects fromchest radiographs. Swingler 1998 briefly comments on
the potential drawbacks of ordering chest radiographs. However,
no data regarding this were collected in either of the included
studies. Listed disadvantages of chest radiographs in Swingler 1998
include the “exposure of ionising radiation, cost (especially if travel
to another facility is necessary), the time and space used waiting
for the radiograph and the need to be seen again by a clinician”.
Theoretical long-term complications of radiation exposure from
chest radiographs, such as risk of malignancy later in life, were not
discussed. Statistics show that the radiation exposure from the use
of chest radiographs is extremely low; a chest radiograph in two
views is associated with an effective dose of ionising radiation of
0.06 to 0.25 mSV (Diederich 2000). This is in comparison to the
average background radiation dose of around 2.4 mSV per year
(WNA 2011). This means that at its most, one chest radiograph
would be equivalent to approximately one month of background
radiation, i.e. there is essentially a negligible risk of malignancy in
the long term with a single chest radiograph.
Another feature of chest radiographs that is worth mentioning is
the discovery of incidental findings, whichmay be advantageous or
disadvantageous. For example, in Bushyhead 1983 there were 17
intrathoracic masses detected, six of which were absent on follow-
up radiographs and the remainder proving to be acute infiltrate,
pericardial cyst, hiatus hernia and granulomas. However, one mass
proved to be lung cancer in a 74-year old man. Chest radiographs
may at times find non-specific nodules which more likely than
not are benign but nonetheless require follow-up (Gould 2007).
This may mean further investigations such as biopsies to rule out
malignancy - these additional tests each have their own associated
morbidity. In cases of malignancy found on chest radiographs
requested for clinically suspected pneumonia, themalignancy may
be the primary cause of the pneumonia (e.g. the tumour causes
bronchial obstruction and pneumonia may be the complication
of the tumour).
Overall completeness and applicability of
evidence
Both of the included studies provided some relevant evidence for
the objectives of this review. However, our review included objec-
tives which were not objectives of the included trials and, there-
fore, there were no results regarding this. One of our primary out-
comes was to assess mortality and this was not assessed by either
of the studies. Our other primary outcome was to investigate the
time to resolution of clinical signs and symptoms. However, given
that the reported data are incomplete, results could not be pooled
together in ameta-analysis. In addition, our secondary outcome of
assessing hospitalisation rates was only reported by Swingler 1998.
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Other secondary outcomes, such as complications of infection and
adverse effects from chest radiographs, were not assessed by either
study. This limits the amount of evidence we could analyze. Fur-
thermore, as the participant population in Bushyhead 1983 were
adults whilst the participants in Swingler 1998 were children, ex-
trapolation of these results to come to a general conclusion may
be inappropriate and of uncertain validity.
Quality of the evidence
Despite the large number of participants (2024), given that the
reported data were incomplete, there is limited evidence to for-
mulate robust conclusions regarding the objectives of our review.
We assessed both RCTs as having a high risk of bias with regards
to selection bias and likely imprecision of results and, hence, we
downgraded them to ’low’ based on the GRADE working group
grades of evidence (Higgins 2011). Although the results of the
two studies could not be pooled into a meta-analysis, both come
to the same conclusion regarding the use of chest radiographs in
acute LRTIs, except in the subset of patients with infiltrates on
their radiograph.
Potential biases in the review process
Identification of all relevant studies
We used a broad search strategy to ensure that we could ascertain
all relevant trials which met our criteria. It is possible that we may
have missed studies. However, contacting experts in the field did
not yield any other relevant references and therefore we think it is
unlikely that studies were missed.
Introduction of bias
We independently appraised the studies for inclusion as well as for
risk of bias and data extraction in order to minimise the risk of
bias in the review process.
Agreements and disagreements with other
studies or reviews
We are not aware of any other RCTs or systematic reviews available
to compare results with.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The two studies included in our review show that the use of chest
radiographs in acute LRTIs did not result in changes in physician
management or patient outcomes in both adults and children.
However, in the subgroup of patients with infiltrates on their ra-
diograph, use of chest radiographs appears to be of benefit and
was associated with a decrease in the length of illness. Unfortu-
nately, in order to identify infiltrates, a chest radiograph needs to
be performed. It is important to note however, that the quality of
evidence supporting these conclusions is weakened by the lack of
complete data available and the risk of bias of the included studies.
Both the included trials were set in large metropolitan cities,
Bushyhead 1983 in Texas and Swingler 1998 in Cape Town. Al-
though radiological facilities are easily accessible in high-income
countries, in low-income countries, especially in rural areas, access
to such resources can be limited (Chudi 2010). There is very lim-
ited data on the exact scale of this problem. However, the World
Health Organization has estimated that two-thirds of the world’s
population have no access to diagnostic imaging (Maru 2010;
PAHO 2012). In addition to the availability of healthcare facili-
ties, chaotic transportation systems and inaccessible roads further
compound the problem (Chudi 2010). Providing medical care
without the use of these vital diagnostic imaging modalities poses
a risk of delays in diagnoses and timely management. Although
the results of this review found no significant difference in patient
outcomes between those who had a chest radiograph and those
who did not, both studies were set in large cities with relatively
easy access to healthcare facilities. The outcomes may be differ-
ent for patients in a resource poor country or in remote settings
with delayed presentation and limited radiological facilities. Both
Bushyhead 1983 and Swingler 1998 had strict exclusion criteria
whichmay limit the clinical practicability of the results of the trials
as they may not reflect those presenting in clinical practice.
Implications for research
Further research involving both children and adults in remote set-
tings, as well as further exploration of subgroups that might ben-
efit from radiographic imaging (such as patients with infiltrative
infections and or co-morbidities), is needed. Data on adverse ef-
fects from chest radiographs are currently lacking and require fur-
ther investigation. In addition, the ability of chest radiographs to
identify complications in patients not responding adequately to
treatment may be an area of future research.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bushyhead 1983
Methods Randomised controlled trial (Phase III: February 1977 to February 1979)
3-phase study
Participants The study was conducted with 2018 consecutive patients (1502 in Phase III) at emer-
gency room and walk-in clinic of “Brooke Army Medical Center at Fort Sam Houston,
Texas”
“The 2018 patients in the three phases of this study were predominantly retired military
personnel and military dependents; a minority were active-duty Army troops. Most
Participants were Caucasian (79 per cent). There were more women than men; the
patients’ ages were distributed bimodally with peaks at 13 to 20 and 51 to 60 years, with
a mean age of 38.”
Inclusion criteria: “Consenting, nonpregnant, adult patients seeking medical care for
the first time for coughs of less than one month’s duration”
Exclusion criteria: pulse rate of 160 or more, temperature 104 °F (40 °C) or more,
systolic blood pressure 90 mmHg or lower, patients arriving by stretcher
Interventions “The independent variable in this randomised, controlled trial is the availability to the
physician of the chest film results. Dependent variables are the physicians’ management
plans and the patient outcomes.”
Phase I
- Chest radiographs were only taken on physicians’ request and all requested radiographs
were seen
- Resembles normal physician practice
- “The physicians did not try to predict chest radiograph findings and did not make
assessments and plans before seeing the films”
- N = 199
Phase II
- Chest radiographs taken of all patients
- Physicians saw chest radiographs only if they ordered them
- Second physician reviewed chest radiographs and clinical records of patients whose
films were not seen and intervened when plans were dangerously inappropriate
- N = 288
Phase III
- PA (Posterior to Anterior) and lateral chest radiographs taken of all patients
- Determined by lot with 1:1 odds randomisation for whether physicians would receive
the radiology report and chest radiograph
-The physicians recorded their estimate of themost likely finding on the chest radiograph,
the probability of this finding, the probability of an infiltrate on the chest radiograph
and the probable microbiological cause of the illness
- Physicians wrote down whether they wished to order a chest radiograph and why they
wanted to. This had no bearing on whether physicians saw the radiographs
- Physicians randomised to the intervention group were allowed to change diagnosis and
management plans on the basis of radiology results
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Bushyhead 1983 (Continued)
- N = 1502 (chest radiographs provided in 739 patients, radiographs not provided in
763)
Outcomes The effect of chest radiographs on the management and clinical course of patients with
acute cough
- “Effectiveness of pneumonia diagnosis and treatment”
- “Effect of the chest film on physicians’ plans”
- “Effect of chest radiograph on illness outcome”
- “Effect of study design on physicians’ decisions”
Notes “Evaluation of the usefulness of chest radiographs in the care of patients presenting for
the first time with acute cough”
“We assume that a test is valuable if its use results in effective changes in patient man-
agement plans or better patient outcomes.”
Only Phase III results were relevant to our review - hence only Phase III results were
discussed
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Phase I - “To ensure a study population
comparable with that of Phase III, in Phase
I we selected for participation only patients
who verbally agreed to the Phase III proto-
col”
Phase III - “We determined by lot, with 1:
1 odds, whether or not the physician caring
for the patient would receive the chest films
and the radiologist’s readings”
It is not described how the random num-
bers or “lot” were generated
Allocation concealment (selection bias) Low risk “The physicians had to make their diag-
nostic, treatment, and follow-up decisions
before patient randomisation but after the
clinical evaluation of the patient. These
plans could be revised only if the patient
were randomised to the group whose chest
films and radiologists’ readings were made
available, and then only after the physician
reviewed this information.”
Phase I
- “Chest films were taken only on physi-
cians’ requests, and the physicians saw all
requested chest radiographs”
- “This phase resembled ordinary physician
practice”
- Allocation concealment not applicable as
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Bushyhead 1983 (Continued)
this phase aims to model the day-to-day
practice for a ’gold standard’
Phase II
- “We took chest radiographs of all pa-
tients. However, physicians saw the chest
films only if they had ordered them.”
Phase III
- “Without knowledge of chest film results.
.. physicians reviewed and checked the his-
tory and performed a standard physical ex-
amination”
- “We required clinicians to record diag-
noses and management plans for all pa-
tients before they knew whether or not
theywould see the chest films...They noted
whether they wished to order a chest radio-
graph for the patient and if so, why. These
decisions had no bearing on whether the
physicians saw the radiographs.”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “Primary outcome (time to recovery) as-
sessed blind to treatment group. Assess-
ment of secondary outcomes was not
blinded.”
“Radiology residents, with staff radiologists
available for consultation, read each chest
radiograph. The only clinical information
available to them was that the patient had
an acute cough. When available, previous
chest films were used in reading the films..
. ”
“Without knowledge of chest film results,
research assistants collected a standard his-
tory from all patients.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analysis was by intention-to-treat
“However, when physicians felt that view-
ing the films was essential to the patients’
health, the patients were excluded from
randomisation, and physicians saw their
chest films. This occurred with only 2 per
cent of patients.”
Selective reporting (reporting bias) Low risk No trial protocol was available. However,
all outcomes were reported
Other bias Unclear risk “For ethical reasons, a physician not other-
wise active in the study reviewed the med-
ical records and chest films of all patients
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Bushyhead 1983 (Continued)
whose films were not given to their physi-
cians. The reviewing physician did not in-
tervene in the patient’s care unless manage-
ment plans seemed dangerously inappro-
priate.”
“As in Phase III, a second physician re-
viewed the radiographs and clinical records
of all patients whose films were not seen by
their clinicians, and intervened when plans
were believed dangerously inappropriate.”
No conflicts of interest and financial dis-
closures reported
Swingler 1998
Methods Randomised controlled trial (September 1995 to September 1996 “on weekday morn-
ings”)
Participants 581 patients enrolled. 522 allocated to radiograph or to the control group (59 excluded)
Inclusion criteria:
“Children aged 2 to 59 months who presented to the Red Cross Children’s Hospital
[Cape Town] as their first contact were eligible for this study if they met the WHO case
definition for pneumonia (i.e. cough and tachypnoea but drinking well and without
chest indrawing, cyanosis, abnormal level of consciousness or stridor).”
“Tachypnoea was defined as a respiratory rate of 50 breaths or more/min in children
aged 2 to 11 months, and 40 breaths or more/min in children aged 12 months or more.
”
Exclusion criteria: “cough of more than 14 days duration, history of current household
contact with active tuberculosis, a localised wheeze, clinical signs of cardiac failure or the
clinician’s assessment that a chest radiograph was mandatory”
“The study was done in the primary general outpatients section. Patients were enrolled
from September, 1995, to September, 1996, on weekday mornings. An experienced
registered nurse screened all waiting patients, and identified eligible individuals. Baseline
information collected at this stage included age, weight, duration of symptoms before
presentation, and respiratory rate.”
N = 522
Interventions “Eligible patients identified by the nursewere seenby a clinician. After themedical history
of each patient was taken and an examination done, eligible patients were allocated to
the radiograph or to the control group.”
“The intervention was the use of a chest radiograph (anteroposterior and lateral views)
. The chest radiograph was viewed by the clinician and a routine report supplied by the
duty paediatric radiologist or radiology registrar was available with the films. The control
was standard of care without a chest radiograph. All other management was entirely at
the discretion of the clinician.”
- N = 286 allocated to have chest radiograph
- 13 did not have it done - 273 children X-rayed
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Swingler 1998 (Continued)
Outcomes “The primary outcome measure was time to recovery, measured by twice weekly struc-
tured telephone interviews of the subset of 295 participants contactable by telephone.”
“Respondents were asked ’Is (child’s name) completely well yet?’ If the answer was ’Yes’,
the next questions was ’On what day was he/she last sick?’. Answers to three of the ques-
tions in the questionnaire (subsequent visits and admissions to the Children’s Hospital
and subsequent chest radiographs done there) were verified by examination of the clinical
records”
“Subsidiary outcomes were management options used (additional tests ordered, number
of drugs per prescription, antibiotic use, follow-up appointment, and immediate admis-
sion to hospital) and other clinical outcomes (return visits and later hospital admission)
. All subsidiary outcomes were ascertained by examination of clinical records of all pa-
tients by the principal investigator (whether contactable by telephone or not), except for
visits to facilities other than the Children’s Hospital, which were measured by the above
telephone interview.”
Notes “The aim of this study was to quantify the effect of the use of chest radiographs on the
management and clinical outcome in children with ambulatory acute lower respiratory
tract infection, and todeterminewhether any such effectwas dependent on the experience
of the clinician”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “..the random allocation [was] generated in
advance by the principal investigator (by
tossing a coin).”
Allocation concealment (selection bias) High risk “Allocation was done by the clinician open-
ing a sealed sequentially numbered manila
envelope attached to the consultation sheet
and containing the random allocation...”
“If a patient was excluded by the clinician
before randomisation the sealed envelope
was returned to the principal investigator.
The return of envelopes was audited.”
“There were no differences in baseline char-
acteristics between groups or between ran-
domised and excluded patients.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The telephone interviewer was not in-
formed of the study hypothesis, was blind
to the randomisation status of the patients,
and had no contact with the hospital other
than through the principal investigator.On
casual enquiry at the end of the study, the
interviewer had guessed only that the study
dealt with chest infections.”
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Swingler 1998 (Continued)
“Coding and cleaning of telephone ques-
tionnaire datawas donewithout knowledge
of treatment group by the principal inves-
tigator on a separate data capture sheet and
in a separate database.”
Incomplete outcome data (attrition bias)
All outcomes
High risk “Patients were analyzed by intention-to-
treat”
“Of the 581 eligible patients identified by
the registered nurse, 59 (26 contactable by
telephone) were excluded by the clinicians
before randomisation. The remaining 522
patients were randomly allocated, 259 to
the radiograph group and 263 to the con-
trol group. Four (1.5%) patients in the ra-
diograph group did not receive the inter-
vention whereas 7 (2.7%) of the control
group had a radiograph on the day of ran-
domisation”
“295 (77.5%) of the patients providing a
telephone number were followed till recov-
ery or censored at 28 days. Of the 522 par-
ticipants 518 (99.2%) record sheets of the
first consultationwere retrieved, and all 522
folders for assessment of subsequent visits.
”
“Although 22% of participants who had a
telephone number were lost to follow-up:
loss was similar between treatment groups.
In addition, the lack of effect of a chest ra-
diograph measured by telephone interview
is consistent with the lack of effect on out-
comes measured by examination of clini-
cal records, where follow-up was virtually
complete.”
Selective reporting (reporting bias) Low risk No trial protocol was available. However,
all outcomes were reported
Other bias Unclear risk “Reliability of record review was assessed
by repeat examination of a 10% random
sample of clinical records by a second ob-
server not involved in the study. 12 items
were assessed: exclusion before randomisa-
tion, treatment allocation, clinician’s per-
ceived need for chest radiograph, diagno-
sis, and the outcome variable listed...”
No conflicts of interest and financial dis-
closures reported.However, “this study was
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Swingler 1998 (Continued)
supported by the Medical Research Coun-
cil of South Africa and the University of
Cape Town.”
Note: potential recruitment bias as “Pa-
tients were enrolled from September 1995
to September 1996 on weekday mornings.”
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bourayou 2011 Not a randomised controlled trial. “We have attempted to clarify [chest radiographs’] diagnostic value in community
acquired pneumonia in children through a literature review...”
Briel 2006 Study outcomes not relevant to our review outcomes:
“Prevalence of diagnostic tests”
“Association between patient characteristics and use of tests”
“Association between test results and diagnosis and treatment”
“Association between test use and patient satisfaction and enablement”
“GPs relied on test results when making decisions about diagnosis & antibiotic treatment”. However, study does
not distinguish between chest radiographs and other blood tests
Colucci 2012 “One year retrospective study of children...at 2 community hospitals...”
“To determine if the disposition and therapeutic interventions for the children directly correlate to the radiography”
Lynch 2004 Outcomes not relevant to our review outcomes. “The primary outcome variable was the difference in the sensitivity
and specificity of the emergency physicians’ interpretations of chest radiographs with access to two views (frontal
and lateral) versus one view (frontal for children with suspected pneumonia.”
“A secondary outcome included the change in management provided by the review of the two views by the
radiologist.”
Ralston 2012 Not a randomised controlled trial. “Our objective was to reduce utilization of unnecessary therapies in the inpatient
care of bronchiolitis across a diverse network of clinical sites”
“We formed a voluntaryquality improvement collaborative of paediatric hospitals for the purpose of benchmarking
the use of bronchodilators, steroids, chest radiography, chest physiotherapy, and viral testing in bronchiolitis using
hospital administrative data. We shared resources within the network, including protocols, scores, order sets, and
key bibliographies, and established group norms for decreasing utilization.”
Swingler 2000 Not a randomised controlled trial. Appears to be a selected case review of tuberculosis of a previously published
study (Swingler 1998). Swingler 1998 is already included in our review
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D A T A A N D A N A L Y S E S
Comparison 1. Chest radiograph versus management without chest radiograph (children only)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Time to resolution of clinical
signs and symptoms
1 518 Mean Difference (IV, Fixed, 95% CI) 0.0 [-1.81, 1.81]
2 Hospitalisation rates 1 518 Risk Ratio (M-H, Fixed, 95% CI) 2.03 [0.77, 5.33]
Analysis 1.1. Comparison 1 Chest radiograph versus management without chest radiograph (children only),
Outcome 1 Time to resolution of clinical signs and symptoms.
Review: Chest radiographs for acute lower respiratory tract infections
Comparison: 1 Chest radiograph versus management without chest radiograph (children only)
Outcome: 1 Time to resolution of clinical signs and symptoms
Study or subgroup Chest radiographs
No chest
radio-
graphs
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Swingler 1998 257 0 (8.2) 261 0 (12.4) 100.0 % 0.0 [ -1.81, 1.81 ]
Total (95% CI) 257 261 100.0 % 0.0 [ -1.81, 1.81 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours chest radiographs Favours no radiographs
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Analysis 1.2. Comparison 1 Chest radiograph versus management without chest radiograph (children only),
Outcome 2 Hospitalisation rates.
Review: Chest radiographs for acute lower respiratory tract infections
Comparison: 1 Chest radiograph versus management without chest radiograph (children only)
Outcome: 2 Hospitalisation rates
Study or subgroup
Favours
chest
radiographs
Favours no
radiographs Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Swingler 1998 12/257 6/261 100.0 % 2.03 [ 0.77, 5.33 ]
Total (95% CI) 257 261 100.0 % 2.03 [ 0.77, 5.33 ]
Total events: 12 (Favours chest radiographs), 6 (Favours no radiographs)
Heterogeneity: not applicable
Test for overall effect: Z = 1.44 (P = 0.15)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Favours chest radiographs Favours no radiographs
A D D I T I O N A L T A B L E S
Table 1. Time to resolution of clinical signs and symptoms (children only)
Study Chest radiograph Without chest radiograph
Median (days) SD Total Median (days) SD Total
Swingler 1998 7 8.2 257 7 12.4 261
Chest radiograph versus management without chest radiograph (children only), outcome: 1.1 Time to resolution of clinical signs and
symptoms.
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
1 exp Radiography, Thoracic/
2 ((chest or lung* or thora*) adj3 (radiograph* or radiogram* or radiology or roentgen* or x-ray* or x ray* or xray*)).tw.
3 1 or 2
4 exp Respiratory Tract Infections/
5 acute respiratory infection*.tw.
6 lower respiratory infection*.tw.
7 lower respiratory tract infection*.tw.
8 exp Pneumonia/
9 (pneumon* or bronchopneumon* or pleuropneumon*).tw.
10 exp Bronchitis/
11 (bronchit* or bronchiolit*).tw.
12 exp Empyema/
13 empyema.tw.
14 Cough/
15 cough*.tw.
16 wheez*.tw.
17 Hemoptysis/
18 (hemoptysis or haemoptysis).tw.
19 Sputum/
20 sputum.tw.
21 fever/ or “fever of unknown origin”/
22 (fever* or pyrexia).tw.
23 exp Pleurisy/
24 (pleurisy or pleuritis).tw.
25 Pleural Effusion/
26 exp Dyspnea/
27 (dyspnoea or dyspnea).tw.
28 Respiratory Sounds/
29 (rales or crackles or rhonchi).tw.
30 Lung abscess/
31 (lung abscess* or pulmonary abscess*).tw.
32 or/4-31
33 3 and 32
Appendix 2. Embase.com search strategy
#38. #34 AND #37
#37. #35 OR #36
#36. random*:ab,ti OR placebo*:ab,ti OR factorial*:ab,ti OR crossover*:ab,ti OR ’cross over’:ab,ti OR ’cross-over’:ab,ti OR volunteer*:
ab,ti OR allocat*:ab,ti OR assign*:ab,ti OR ((singl* OR doubl*) NEAR/1 blind*):ab,ti
#35. ’randomized controlled trial’/expOR ’single blind procedure’/exp OR ’double blind procedure’/expOR ’crossover procedure’/exp
#34. #4 AND #33
#33. #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #
20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26
OR #27 OR #28 OR #29 OR #30 OR #31 OR #32
#32. ’lung abscess’:ab,ti OR ’pulmonary abscess’:ab,ti
#31. ’lung abscess’/de
#30. rales:ab,ti OR crackles:ab,ti OR rhonchi:ab,ti
#29. ’abnormal respiratory sound’/de
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#28. dyspnea:ab,ti OR dyspnoea:ab,ti
#27. ’dyspnea’/exp
#26. ’pleura effusion’/de
#25. pleurisy:ab,ti OR pleuritis:ab,ti
#24. ’pleurisy’/exp
#23. fever*:ab,ti OR pyrexia:ab,ti
#22. ’pyrexia idiopathica’/de
#21. ’fever’/de
#20. sputum:ab,ti
#19. ’sputum’/de AND [embase]/lim
#18. hemoptysis:ab,ti OR haemoptysis:ab,ti
#17. ’hemoptysis’/de
#16. wheez*:ab,ti
#15. ’wheezing’/de
#14. cough*:ab,ti
#13. ’coughing’/exp
#12. empyema:ab,ti
#11. ’empyema’/exp
#10. bronchit*:ab,ti OR bronchiolit*:ab,ti
#9. ’bronchitis’/exp
#8. pneumon*:ab,ti OR bronchopneumon*:ab,ti OR pleuropneumon*:ab,ti
#7. ’pneumonia’/exp
#6. ’acute respiratory infection’:ab,ti OR ’acute respiratory infections’:ab,ti OR ’lower respiratory infection’:ab,ti OR ’lower respiratory
infectons’:ab,ti OR ’lower respiratory tract infection’:ab,ti OR ’lower respiratory tract infections’:ab,ti
#5. ’lower respiratory tract infection’/exp
#4. #1 OR #2 OR #3
#3. ’chest xray’:ab,ti OR ’chest x-ray’:ab,ti OR ’lung xray’:ab,ti OR ’lung x-ray’:ab,ti OR ’lung x ray’:ab,ti OR ’thoracic xray’:ab,ti OR
’thorax xray’:ab,ti OR ’thoracic x-ray’:ab,ti OR ’thorax x-ray’:ab,ti OR ’thoracic x ray’:ab,ti OR ’thorax x ray’:ab,ti
#2. ((chest OR lung* OR thora*) NEAR/3 (radiograph* OR radiogram* OR radiology OR roentgen*)):ab,ti
#1. ’thorax radiography’/exp
Appendix 3. CINAHL (Ebsco) search strategy
S52 S42 and S51
S51 S43 or S44 or S45 or S46 or S47 or S48 or S49 or S50
S50 (MH “Quantitative Studies”)
S49 TI placebo* or AB placebo*
S48 (MH “Placebos”)
S47 TI random* or AB random*
S46 TI (singl* blind* or doubl* blind* or tripl* blind* or trebl* blind* or singl* mask* or doubl* mask* or tripl* mask* or trebl* mask*)
or AB (singl* blind* or doubl* blind* or tripl* blind* or trebl* blind* or singl*mask* or doubl* mask* or tripl* mask* or trebl* mask*)
S45 TI clinic* trial* or AB clinic* trial*
S44 PT clinical trial
S43 (MH “Clinical Trials+”)
S42 S14 and S41
S41 S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32
or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40
S40 TI (lung abscess* or pulmonary abscess*) or AB (lung abscess* or pulmonary abscess*)
S39 (MH “Lung Abscess”)
S38 TI (rales or crackles or rhonchi) or AB (rales or crackles or rhonchi)
S37 (MH “Respiratory Sounds”)
S36 TI (dyspnea or dyspnoea) or AB (dyspnea or dyspnoea)
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S35 (MH “Dyspnea+”)
S34 (MH “Pleural Effusion”)
S33 TI (pleurisy or pleuritis) or AB (pleurisy or pleuritis)
S32 (MH “Pleurisy”)
S31 TI (fever* or pyrexia) or AB (fever or pyrexia)
S30 (MH “Fever”) OR (MH “Fever of Unknown Origin”)
S29 TI sputum or AB sputum
S28 (MH “Sputum”)
S27 TI (hemoptysis or haemoptysis) or AB (hemoptysis or haemoptysis)
S26 (MH “Hemoptysis”)
S25 TI wheez* or AB wheez*
S24 TI cough* or AB cough*
S23 (MH “Cough”)
S22 TI empyema or AB empyema
S21 (MH “Empyema”)
S20 (bronchit* or bronchiolit*) or (bronchit* or bronchiolit*)
S19 (MH “Bronchitis+”)
S18 TI (pneumon* or bronchopneumon* or pleuropneumon*) or AB (pneumon* or bronchopneumon* or pleuropneumon*)
S17 (MH “Pneumonia+”)
S16 TI (acute respiratory infection* or lower respiratory infection* or lower respiratory tract infection*) or AB (acute respiratory
infection* or lower respiratory infection* or lower respiratory tract infection*)
S15 (MH “Respiratory Tract Infections+”)
S14 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13
S13 TI thora* N3 roentgeno* or AB thora* N3 roentgeno*
S12 TI lung* N3 roentgeno* or AB lung* N3 roentgeno*
S11 TI chest N3 roentgeno* or AB chest N3 roentgeno*
S10 TI thora* N3 radiology* or AB thora* N3 radiology*
S9 TI lung* N3 radiology* or AB lung* N3 radiology*
S8 TI chest* N3 radiology* or AB chest* N3 radiology*
S7 TI thora* N3 radiogra* or AB thora* N3 radiogra*
S6 TI lung* N3 radiogra* or AB lung* N3 radiogra*
S5 TI chest* N3 radiogra* or AB chest* N3 radiogra*
S4 TI thora* N3 x#ray* or AB thora* N3 x#ray*
S3 TI lung* N3 x#ray* or AB lung* N3 x#ray*
S2 TI chest N3 x#ray* or AB chest N3 x#ray*
S1 (MH “Radiography, Thoracic+”)
Appendix 4. LILACS search strategy
(mh:“Radiography, Thoracic” OR mh:e01.370.350.700.730$ OR “Radiografía Torácica” OR “chest radiograph” OR “Radiografías
Pulmonares” OR “Radiografia Pulmonar” OR “chest xray” OR “chest x-ray” OR “chest x ray” OR “Radiografia de tórax” OR “Rayos x
de tórax” OR “Radiografia del pulmon”OR “chest radiology” OR “chest radiogram”) AND (mh:“Respiratory Tract Infections” ORmh:
c01.539.739$ OR mh:c08.730$ OR “Infecciones del Sistema Respiratorio” OR “Infecções Respiratórias” OR “Infecciones de las Vías
Respiratorias” OR “Infecciones del Aparato Respiratorio” OR “Infecciones del Tracto Respiratorio” OR “Infecciones Respiratorias” OR
“Infecções das Vias Respiratórias” OR “Infecções do Aparelho Respiratório” OR “Infecções do Sistema Respiratório” OR “Infecções
do Trato Respiratório” OR “acute respiratory infection” OR “acute respiratory infections” OR “lower respiratory infection” OR “lower
respiratory infections” OR “lower respiratory tract infection” OR “lower respiratory tract infection” OR mh:pneumonia OR mh:
c08.381.677$ OR mh:c08.730.610$ OR neumonía OR pneumonia OR “Inflamación Experimental del Pulmón” OR “Inflamación
del Pulmón” OR “Neumonía Lobar” OR neumonitis OR “Inflamación Pulmonar” OR pneumonía OR pulmonía OR “Inflamação
Experimental dos Pulmões” OR “Inflamação do Pulmão” OR “Pneumonia Lobar” OR pneumonite OR “Inflamação Pulmonar” OR
pulmoniaORmh:bronchopneumoniaORbronconeumoníaORbroncopneumoniaORbronchopneumon$ORmh:pleuropneumonia
OR pleuroneumonía OR pleuropneumonia OR pleuropneumon$ ORmh:bronchitis OR bronchit$ OR bronquitis OR bronquite OR
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mh:c08.127.446$ OR mh:c08.381.495.146$ OR mh:c08.730.099$ OR bronchiolit$ OR bronquiolitis OR bronquiolite OR mh:
empyema OR mh:c01.539.830.305$ OR empyema OR empiema OR mh:cough OR cough$ OR tos$ OR wheez$ OR “Ruidos de la
Respiración” OR “Sonidos de la Respiración” OR “Ruidos Pulmonares” OR “Ruidos del Pulmón” OR “Roce Pleural” OR estertores
OR ronquidos OR roncus OR sibilancias OR sibilancia OR crepitación OR “Sonidos Respiratorios” OR “Ruídos Respiratórios” OR
“Sons da Respiração” OR “Ruídos da Respiração” OR “Ruídos Traqueobrônquicos” OR “Ruídos Traqueo-Brônquicos” OR “Sons
Pulmonares” OR “Atrito Pleural” OR estertores OR roncos OR crepitação OR “Estertor Crepitante” OR mh:“Respiratory Sounds”
OR rales OR crackles OR rhonchi OR mh:hemoptysis OR hemopt$ OR mh:sputum OR sputum OR esputo OR escarro OR mh:
fever OR fever OR fiebre OR febre OR pyrexia OR mh:“Fever of Unknown Origin” OR “Fiebre de Origen Desconocido” OR “Febre
de Causa Desconhecida” OR mh:pleurisy OR pleurisy OR pleuresia OR mh:“Pleural Effusion” OR “pleural effusion” OR “Derrame
Pleural” OR mh:dyspnea OR dyspnea OR dyspnoea OR disnea OR dispnéia ORmh:“Lung Abscess” OR “lung abscess” OR “Absceso
Pulmonar” OR “Abscesso Pulmonar”)
Appendix 5. ClinicalTrials.gov search strategy
Interventional studies
Condition: lower respiratory tract infections OR pneumonia OR bronchitis OR empyema OR cough OR wheeze OR wheezing OR
pleurisy
Intervention: radiograph OR radiography OR x-ray OR radiology OR roentgenogram
Appendix 6. WHO ICTRP search strategy
Pneumonia AND chest x-ray
(Bronchitis
Wheez*
Empyema
Cough*
Respiratory infection)
Pneumonia AND chest radiograph
(Bronchitis
Wheez*
Empyema
Cough*
Respiratory infection)
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drafted and reviewed the protocol. AC and JC independently assessed and selected trials for inclusion with input from LM and MvD.
AC, JC and LM drafted and edited the review. MvD edited, reviewed and provided guidance throughout the writing of this review.
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• Bond University, Australia.
Primary Health Care Research and Evaluation Program (PHCRED)
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The reference to ’magnetic resonance imaging (MRI)’ was removed from the Description of the intervention as they are rarely, if ever,
used in the management of LRTIs. The use of the word ’X-ray’ was changed to ’radiograph’ throughout the review apart from the ’Plain
language summary’.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Radiography, Thoracic; Acute Disease; Hospitalization [statistics & numerical data]; Randomized Controlled Trials as Topic; Respi-
ratory Tract Infections [∗diagnostic imaging]
MeSH check words
Adult; Child; Humans
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